| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K42260513 |
| PharmacoGx | BRD-K42260513 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TTC16 | CTRPv2 | pan-cancer | AAC | 0.41 | 4e-15 |
| mRNA | RGPD2 | CTRPv2 | pan-cancer | AAC | 0.42 | 4e-15 |
| mRNA | GNA15 | CTRPv2 | pan-cancer | AAC | 0.44 | 8e-15 |
| mRNA | TRAT1 | CTRPv2 | pan-cancer | AAC | 0.39 | 8e-14 |
| mRNA | RAG1 | CTRPv2 | pan-cancer | AAC | 0.4 | 1e-13 |
| mRNA | ADA | CTRPv2 | pan-cancer | AAC | 0.4 | 2e-13 |
| mRNA | OR10T2 | CTRPv2 | pan-cancer | AAC | 0.38 | 3e-13 |
| mRNA | SASH3 | CTRPv2 | pan-cancer | AAC | 0.45 | 6e-13 |
| mRNA | SOCS1 | CTRPv2 | pan-cancer | AAC | 0.39 | 2e-12 |
| mRNA | CD247 | CTRPv2 | pan-cancer | AAC | 0.4 | 2e-12 |
